A 50-year-old female with generalized anxiety disorder and comorbid fibromyalgia is currently taking gabapentin 600 mg three times daily with inconsistent symptom control. She reports that some doses seem to work better than others. The PMHNP considers switching to pregabalin. Which of the following best describes the pharmacokinetic advantage of pregabalin over gabapentin in this scenario?